[go: up one dir, main page]

IL78661A - Bone targeted inhibitors of carbonic anhydrase and methods for the preparation thereof - Google Patents

Bone targeted inhibitors of carbonic anhydrase and methods for the preparation thereof

Info

Publication number
IL78661A
IL78661A IL8678661A IL7866186A IL78661A IL 78661 A IL78661 A IL 78661A IL 8678661 A IL8678661 A IL 8678661A IL 7866186 A IL7866186 A IL 7866186A IL 78661 A IL78661 A IL 78661A
Authority
IL
Israel
Prior art keywords
preparation
carbonic anhydrase
methods
bone
targeted inhibitors
Prior art date
Application number
IL8678661A
Other languages
English (en)
Other versions
IL78661A0 (en
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of IL78661A0 publication Critical patent/IL78661A0/xx
Publication of IL78661A publication Critical patent/IL78661A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL8678661A 1985-05-02 1986-05-02 Bone targeted inhibitors of carbonic anhydrase and methods for the preparation thereof IL78661A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73087385A 1985-05-02 1985-05-02

Publications (2)

Publication Number Publication Date
IL78661A0 IL78661A0 (en) 1986-08-31
IL78661A true IL78661A (en) 1992-08-18

Family

ID=24937140

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8678661A IL78661A (en) 1985-05-02 1986-05-02 Bone targeted inhibitors of carbonic anhydrase and methods for the preparation thereof

Country Status (10)

Country Link
EP (1) EP0201057B1 (pt)
JP (1) JP2578098B2 (pt)
AT (1) ATE82854T1 (pt)
DE (1) DE3687181T2 (pt)
DK (1) DK201486A (pt)
ES (1) ES8802468A1 (pt)
GR (1) GR861167B (pt)
IE (1) IE59801B1 (pt)
IL (1) IL78661A (pt)
PT (1) PT82499B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK224589A (da) * 1988-05-09 1989-11-10 Merck & Co Inc Polymalonsyreforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
JPH0778024B2 (ja) * 1988-10-14 1995-08-23 藤沢薬品工業株式会社 医薬化合物とジホスホン酸誘導体の結合体を含有する医薬用製剤
US4990523A (en) * 1989-06-19 1991-02-05 A. H. Robins Company, Incorporated Treatment of chronic inflammatory joint disease with arylsulfonamides
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
US5183815A (en) * 1991-01-22 1993-02-02 Merck & Co., Inc. Bone acting agents
RU2138507C1 (ru) * 1993-03-25 1999-09-27 Искра Индастри Ко., Лтд. Производные тетрациклина
JPH07242548A (ja) * 1993-12-29 1995-09-19 Isukura Sangyo Kk 骨吸収抑制・骨形成促進剤
US5880111A (en) * 1995-06-07 1999-03-09 Farcasiu; Dan Therapeutic derivations of diphosphonates
PL336231A1 (en) 1997-02-13 2000-06-19 Bone Care International System for aimed therapeutic delivery of vitamin d compounds
DE19828068C2 (de) * 1998-06-24 2003-12-18 Peter Dietsch Mittel zur spezifischen Hemmung osteoklastärer Knochenresorption
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
AU4682700A (en) * 1999-04-30 2000-11-17 Research Corporation Technologies, Inc. Bone targeting agents for osteoporosis
US7829074B2 (en) 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
US6436386B1 (en) * 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
DE3583887D1 (de) * 1984-04-30 1991-10-02 Procter & Gamble Ausruestung fuer die behandlung der osteoporose.

Also Published As

Publication number Publication date
DE3687181D1 (de) 1993-01-14
ES555118A0 (es) 1988-07-16
IE861148L (en) 1986-11-02
IE59801B1 (en) 1994-04-06
ATE82854T1 (de) 1992-12-15
PT82499B (pt) 1988-10-14
EP0201057A3 (en) 1989-10-18
DE3687181T2 (de) 1993-04-15
GR861167B (en) 1986-09-30
JP2578098B2 (ja) 1997-02-05
IL78661A0 (en) 1986-08-31
JPS6226256A (ja) 1987-02-04
PT82499A (en) 1986-06-01
DK201486A (da) 1986-11-04
DK201486D0 (da) 1986-05-01
EP0201057A2 (en) 1986-11-12
ES8802468A1 (es) 1988-07-16
EP0201057B1 (en) 1992-12-02

Similar Documents

Publication Publication Date Title
IL78661A0 (en) Bone targeted inhibitors of carbonic anhydrase and methods for the preparation thereof
MY130145A (en) Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
UA41906C2 (uk) Спосіб лікування неврологічних порушень, викликаних травмами
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
HUT71344A (en) Pharmaceutical compositions for inhibiting thrombin containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation
TW225532B (pt)
IL81887A0 (en) Dihydroisoxazole derivatives,their preparation and pharmaceutical compositions containing them
EP0471756A4 (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
EP0727994A4 (en) ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE ETODOLIC ACID
EP0318935A3 (en) Substituted alpha-amino acids having pharmaceutical activity
GB9109972D0 (en) Therapeutic compounds
NZ218170A (en) Piperidine derivatives and pharmaceutical compositions
HUT52377A (en) Process for producing pharmaceutical compositions comprising 3-substituted-2-oxindole-1-carboxamide derivatives as active ingredient
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
HUT52376A (en) Process for producing pharmaceutical compositions comprising 3-substituted-2-oxindole-1-carboxamide derivatives as active ingredient
AU2003271811A8 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
HUT50821A (en) Process for producing new ester derivatives of acyclovir and pharmaceutical compositions comprising such compound
AU567018B2 (en) Prazosin-pirbuterol combination for bronchoduation
NZ223646A (en) Nedocromil calcium and pharmaceutical compositions
DK492989D0 (da) Aminopyrrolidinon, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling deraf
HUT62303A (en) Process for producing n-substituted aminomethane diphosphonic acids and pharmaceutical compositions comprising same as active ingredient
HUT59100A (en) Process for producing acetylene derivatives of calcium-absorbtion inhibiting activity and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void